Although the originally scheduled ACC/WCC 2020 meeting was cancelled, it is still happening in part as a virtual meeting starting tomorrow. 

https://accscientificsession.acc.org/

There are still two Resverlogix posters. Both posters are already up on the ACC website in the eAbstract section: https://cslide-us.ctimeetingtech.com/acc2020_eposter/attendee/eposter/browse.

You may need to register with your name and email to access.

1315-168 / 168 - THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL

https://www.abstractsonline.com/pp8/#!/8992/presentation/23270

 1080-05 - EPIGENETIC READER INHIBITOR APABETALONE (RVX-208) COUNTERS PROINFLAMMATORY HYPERACTIVATION OF CD14+ MONOCYTES FROM PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE

https://www.abstractsonline.com/pp8/#!/8992/presentation/12275 

The second one was originally scheduled to be a moderated poster session. From the ACC virtual schedule, it sounds like these will still have an audio presentation of the poster starting tomorrow at 8 AM CT.

BDAZ